It’s unclear how much Mark Cuban can or will disrupt the pharmaceutical industry, but he told The Athletic he’s in the business for the long haul.For the foreseeable future, he’s willing to deficit spend for his startup Mark Cuban Cost Plus Drug Co., according to the June 14 report. “We’re not losing that much money,” […]

Author